Results 51 to 60 of about 16,160 (225)

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Neurological Entity?

open access: yesMedicina, 2021
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a disorder of unknown physiopathology with multisystemic repercussions, framed in ICD-11 under the heading of neurology (8E49).
Iñigo Murga Gandasegui   +4 more
doaj   +1 more source

Sensorimotor control in the congenital absence of functional muscle spindles

open access: yesExperimental Physiology
Hereditary sensory and autonomic neuropathy type III (HSAN III), also known as familial dysautonomia or Riley–Day syndrome, results from an autosomal recessive genetic mutation that causes a selective loss of specific sensory neurones, leading to greatly
Vaughan G. Macefield   +4 more
doaj   +1 more source

Post-COVID-19 Syndrome and Related Dysautonomia: Reduced Quality of Life, Increased Anxiety and Manifestation of Depressive Symptoms: Evidence from Greece

open access: yesActa Medica Lituanica, 2023
Background: Post-COVID-19 syndrome affects a significant number of SARS-CoV-2 infected individuals, even in asymptomatic cases causing several neurological and neuropsychiatric symptoms and signs.
Petros Galanis   +8 more
doaj   +1 more source

The psychophysiology of dysautonomia [PDF]

open access: yes, 2016
Modern theories of emotion emphasise the role of homeostatic requirements in motivating and shaping behaviour and link emotions with motor and autonomic responses to define physiological, behavioural and neurobiological phenomena initiated by the ...
Owens, AP
core  

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

open access: yesMovement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz   +2 more
wiley   +1 more source

Dysautonomia in ‘long COVID’: Case report

open access: yes, 2023
Background: The reason for autonomic dysfunction in COVID-19 is yet to get clear, though we tend to notice a few dysautonomia cases during post-COVID-19 manifested most commonly in the form of postural orthostatic tachycardia syndrome (POTS).
Arijita Banerjee, Sumit Kumar
core   +1 more source

Acute dysautonomia following mumps

open access: yes, 1999
Pure acute or subacute dysautonomia is a rare entity. Its etiology is as yet unknown. However, majority of these cases have a preceding viral infection such as herpes simplex, infectious mononucleosis, rubella or coxsackie B.

core   +1 more source

Immune Checkpoint Inhibitor‐Related Dysautonomia in Merkel Cell Carcinoma: A Case Report

open access: yesCancer Reports
Background Immune checkpoint inhibitors (ICIs) are monoclonal antibodies that block inhibitory pathways that cancer cells exploit to suppress T‐cell activation.
Nidhi Kuchimanchi   +3 more
doaj   +1 more source

Dysautonomia following Lyme disease: a key component of post-treatment Lyme disease syndrome?

open access: yesFrontiers in Neurology
Dysautonomia, or dysfunction of the autonomic nervous system (ANS), may occur following an infectious insult and can result in a variety of debilitating, widespread, and often poorly recognized symptoms.
Brittany L. Adler   +3 more
doaj   +1 more source

Clinical Heterogeneity in ME/CFS. A Way to Understand Long-COVID19 Fatigue

open access: yesFrontiers in Psychiatry, 2021
The aim of present paper is to identify clinical phenotypes in a cohort of patients affected of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Ninety-one patients and 22 healthy controls were studied with the following questionnaires, in addition to
Iñigo Murga   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy